# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview
**Paper:** paper.pdf
**Timestamp:** 2026-02-04T03:41:06.280865
**Route:** Direct Google API + PDF
**Tokens:** 27158 in / 546 out
**Response SHA256:** 01dd32af60db7639

---

I have reviewed the draft paper for fatal errors in data-design alignment, regression sanity, completeness, and internal consistency.

**ADVISOR REVIEW**

**1. DATA-DESIGN ALIGNMENT: NO FATAL ERRORS FOUND**
- The treatment timing is consistent with the data coverage. The paper uses mortality data through 2023. States with adoption dates in 2024 and 2025 (e.g., Georgia, Indiana, Ohio) are correctly reclassified as "not-yet-treated" for the duration of the sample (Table 2, Table 14).
- The "First treatment year" definitions are logically consistent with the mid-year convention described in Section 4.3 (e.g., Texas effective 2021-09-01 results in a first full exposure year of 2022).

**2. REGRESSION SANITY: NO FATAL ERRORS FOUND**
- Standard errors in Table 3 and Table 4 are within plausible ranges for mortality rates per 100,000 (roughly 0.7 to 1.1 for coefficients near zero). 
- In Table 3, Column 3 (Log Rate), the standard error (0.095) and coefficient (0.046) are appropriately sized for log outcomes.
- $R^2$ values are between 0 and 1 across all tables.
- No "NA", "NaN", or "Inf" values appear in regression results.

**3. COMPLETENESS: NO FATAL ERRORS FOUND**
- Sample sizes ($N$ or $Num.Obs.$) are clearly reported in all regression tables.
- Standard errors/confidence intervals are present for all point estimates.
- There are no placeholders (e.g., "TBD", "XXX").
- The analysis described in the methodology (Callaway-Sant’Anna, TWFE, Sun-Abraham) is fully reported in the results section and appendices.

**4. INTERNAL CONSISTENCY: NO FATAL ERRORS FOUND**
- The number of jurisdictions matches throughout the text and figures ($N=50$ jurisdictions, excluding Vermont).
- Statistics in the text match the tables (e.g., the TWFE baseline estimate of $-0.117$ in Section 6.2 matches Table 3, Column 1).
- The cohort assignments in Table 2 align with the "Status" displayed in Figure 1 and the composition in Table 14.

**ADVISOR VERDICT: PASS**